aTyr Pharma, Inc. (ATYR)
NASDAQ: ATYR · Real-Time Price · USD
0.8324
+0.0824 (10.99%)
At close: Apr 10, 2026, 4:00 PM EDT
0.8300
-0.0024 (-0.29%)
Pre-market: Apr 13, 2026, 4:03 AM EDT
aTyr Pharma Employees
As of December 31, 2025, aTyr Pharma had 60 total employees, including 58 full-time and 2 part-time employees. The number of employees increased by 1 or 1.69% compared to the previous year.
Employees
60
Change (1Y)
1
Growth (1Y)
1.69%
Revenue / Employee
$3,167
Profits / Employee
-$1,235,300
Market Cap
81.62M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 60 | 1 | 1.69% | 58 | 2 |
| Dec 31, 2024 | 59 | 0 | - | 56 | 3 |
| Dec 31, 2023 | 59 | -11 | -15.71% | 56 | 3 |
| Dec 31, 2022 | 70 | 17 | 32.08% | 65 | 5 |
| Dec 31, 2021 | 53 | 10 | 23.26% | 49 | 4 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Adicet Bio | 102 |
| Fractyl Health | 101 |
| Pelthos Therapeutics | 92 |
| XBiotech | 85 |
| InflaRx | 65 |
| PMV Pharmaceuticals | 54 |
| BeyondSpring | 44 |
| Q32 Bio | 24 |
ATYR News
- 10 days ago - Ethos to Announce First Quarter 2026 Financial Results on May 6, 2026 - GlobeNewsWire
- 19 days ago - Ethos and Banner Life Expand Offering to Bring Final Expense Coverage to More Families - GlobeNewsWire
- 5 weeks ago - aTyr Pharma Announces Fourth Quarter and Full Year 2025 Results and Provides Corporate Update - GlobeNewsWire
- 6 weeks ago - Ethos to Participate in The Citizens Technology Conference - GlobeNewsWire
- 6 weeks ago - Ethos Reports Fourth Quarter and Fiscal Year 2025 Financial Results - GlobeNewsWire
- 7 weeks ago - aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 7 weeks ago - aTyr Pharma to Present at the Leerink Partners Global Healthcare Conference - GlobeNewsWire
- 2 months ago - Ethos to Announce Fourth Quarter 2025 Financial Results on February 25, 2026 - GlobeNewsWire